BPTH — Bio Path Holdings Balance Sheet
0.000.00%
- $1.25m
- $0.07m
Annual balance sheet for Bio Path Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 13.8 | 23.8 | 10.4 | 1.05 | 1.17 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 16 | 26.1 | 15.6 | 3.04 | 3.78 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.519 | 0.428 | 0.356 | 0.178 | 0.107 |
Total Assets | 16.5 | 26.6 | 16 | 3.22 | 3.88 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.17 | 0.958 | 1.68 | 1.91 | 3.29 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 1.41 | 1.11 | 1.8 | 2.78 | 3.73 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 15.1 | 25.5 | 14.2 | 0.441 | 0.154 |
Total Liabilities & Shareholders' Equity | 16.5 | 26.6 | 16 | 3.22 | 3.88 |
Total Common Shares Outstanding |